The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Vor Biopharma Inc (NASDAQ: VOR) closed at $0.95 down -11.85% from its previous closing price of $1.08. In other words, the price has decreased by -$11.85 from its previous closing price. On the day, 0.59 million shares were traded.
Ratios:
For a deeper understanding of Vor Biopharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.69 and its Current Ratio is at 4.69. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on July 26, 2022, initiated with a Outperform rating and assigned the stock a target price of $18.
On April 27, 2022, Goldman started tracking the stock assigning a Neutral rating and target price of $6.
On December 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $26.H.C. Wainwright initiated its Buy rating on December 17, 2021, with a $26 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 13 ’25 when Attar Eyal C. sold 2,227 shares for $1.42 per share. The transaction valued at 3,162 led to the insider holds 126,625 shares of the business.
EYAL ATTAR bought 2,227 shares of VOR for $3,073 on Feb 13 ’25. On Feb 10 ’25, another insider, Attar Eyal C., who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,554 shares for $1.37 each. As a result, the insider received 3,499 and left with 128,852 shares of the company.
Stock Price History:
Over the past 52 weeks, VOR has reached a high of $2.43, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -26.34%, while the 200-Day Moving Average is calculated to be -9.52%.
Shares Statistics:
A total of 124.78M shares are outstanding, with a floating share count of 76.74M. Insiders hold about 38.50% of the company’s shares, while institutions hold 42.90% stake in the company.
